Cardiometabolic Specialists play a crucial role in addressing the complex interplay between cardiovascular health and metabolic disorders such as diabetes, obesity, and hypertension. These experts focus on identifying and managing risk factors that contribute to heart disease and metabolic syndrome, which together significantly increase the likelihood of cardiovascular events. By integrating knowledge from cardiology, endocrinology, and nutrition, they develop personalized treatment plans that aim to improve heart function while optimizing metabolic health. Their approach often includes lifestyle modification, pharmacotherapy, and regular monitoring to reduce the burden of these intertwined conditions. With the rising global prevalence of obesity and diabetes, their expertise has become more vital than ever.
In clinical settings and scientific gatherings, cardiometabolic specialists emphasize the importance of early detection and comprehensive care. They advocate for multidisciplinary collaboration to enhance patient outcomes, combining cutting-edge research with practical interventions. Through continued education and research, these specialists stay abreast of emerging therapies and diagnostic tools that can better predict and prevent cardiometabolic complications. Their work not only improves individual patient prognosis but also contributes to public health strategies aimed at reducing the prevalence of heart disease linked to metabolic abnormalities worldwide. Collaboration between specialists and primary care providers ensures holistic management of patients’ health, making care more efficient and effective.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation